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ABSTRACT 
International Journal of Exercise Science 12(3): 1057-1069, 2019. In long-term exercise training 
studies ( > 6 weeks), improvements in insulin resistance (IR) are amplified by decreased body 
fat and/or increased cardio-respiratory fitness. This presents a challenge in studying the 
independent effects of exercise training. Our study purpose was to determine the effects of 
short-term continuous moderate intensity training (CMIT) and high intensity interval training 
(HIIT) on IR in overweight/obese adults. Participants were stratified into insulin sensitive (IS) 
and IR groups, and randomized into non-exercise control (CNT), CMIT and HIIT sub-groups 
that underwent baseline and post testing. Exercise sessions were 18-24 minutes for 10 
consecutive days. The CMIT sub-group continuously cycled at 60-70% of peak oxygen 
consumption (V ̇O2peak) while the HIIT sub-group performed 60s of cycling at 90-100% V ̇O2peak 
interspersed with 30 seconds of rest. Ninety-five participants (mean age and BMI 23.9 + 3.9 years 
and 32.1 + 5.0 kg/m2) were enrolled into the study. Of these, 63% were IS and 37% had IR. CMIT 
or HIIT did not result in statistically significant improvements in IR. However, the reduction 
(32.4%) in IR observed with HIIT may be of clinical relevance. Cohen’s (d) effect size (ES) for 
HIIT on IR was large (ES: d = -0.9; 95% CI: -1.7, -0.1) while that of CMIT was unclear (ES: d = -
0.2; 95% CI: -1.0, 0.6). In the current study, CMIT or HIIT did not result in statistically significant 
improvements in insulin resistance. Future large-scale studies to clarify and confirm our 
findings are warranted. 
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Insulin resistance commonly arises from a chronic energy surplus associated with  overweight 
and obesity [1]. Individuals who are overweight/obese are at increased risk of cardiometabolic 
disorders associated with insulin resistance including dyslipidaemia, type 2 diabetes and 
cardiovascular diseases (CVDs) [2]. Current strategies for the managements of insulin resistance 
and associated disorders include lifestyle modification (diet and exercise) and pharmacological 
agents such as insulin, metformin and statins [3-5]. Pharmacological agents however, are often 
associated with undesirable side effects such as diarrhea, abnormal dreams and myopathy [6].  
 
Exercise and dietary interventions such as high-fat-low-carbohydrate (HFLC) diet, high protein 
diet and the Mediterranean diet have been reported to result in superior therapeutic effects 
compared with pharmacological agents [7, 8]. Challenges with dietary interventions, however, 
include high cost and weak sustainability [9-11]. Conversely, exercise offers an efficient and cost-
effective alternative for the management of chronic diseases including insulin resistance [12]. A 
large body of evidence indicates that exercise training  results in improved insulin sensitivity, 
and consequently, the concentration of insulin required to bring about 50% of its maximal effect 
on glucose transport is lower [13, 14]. As a result, a maximal insulin stimulus produces a larger 
increase in glucose transport. Exercise, therefore, improves impaired glucose homeostasis 
associated with insulin resistance by regulating insulin action.  
 
Metabolic effects of exercise training are primarily dependent on the intensity and duration of 
the intervention [15, 16]. Chronic training studies have shown that high intensity interval 
training (HIIT) characterized by brief bouts of all-out effort interspersed with recovery, leads to 
similar improvements in metabolic outcomes when compared with traditional continuous 
moderate intensity training (CMIT) currently prescribed for individuals with metabolic 
disorders [17, 18]. Asymptomatic individuals with insulin resistance or type 2 diabetes are 
encouraged to achieve a minimum 30 minutes of moderate intensity (less than 60% of heart rate 
reserve) exercise per day, on at least 5 days per week [19]. Conversely, HIIT requires only 10-
20% of the 150 minutes required for CMIT, with the same or possibly better therapeutic effects 
[20, 21]. However, with long-term training, effects of exercise on insulin action are influenced 
by decreases in body fat and/or improvements in cardiorespiratory fitness, factors which have 
been found to independently improve insulin resistance [22, 23]. As a result, short-term 
interventions (7-10 days) are increasingly being studied to better understand independent 
effects of exercise on insulin resistance. Despite being less understood, short-term HIIT has been 
reported to improve metabolic health in insulin resistant and diabetic patients [24, 25]. In these 
studies, however, the cohorts are often of a single gender, with no distinction made between 
individuals with and without insulin resistance, and no comparison to a non-exercise control 
and CMIT group [26]. The aim of the current randomized controlled trial, therefore, was to 
assess short-term effect of CMIT and HIIT on markers of beta cell function, insulin sensitivity 
and insulin resistance in physically inactive overweight/obese adults. 
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Study participants were male and female adults aged between 18 and 35 years who were 
physically inactive (less than 30 minutes of physical activity five days a week), 
overweight/obese (BMI ≥ 25 kg/m2), non-smokers and did not use medications that are known 
to affect body composition and metabolism.  
 
Staff and Students of the University of KwaZulu-Natal were invited to volunteer to take part in 
the study through posters and social media outlets. Consenting individuals provided written 
consent for participation and publication of the results. The study was conducted between 
August 2016 and October 2017 at the Human Performance Laboratory (HPL) of the University 
of KwaZulu-Natal, Durban, South Africa. A target sample size of 150 was calculated using an 
online sample size calculator (Raosoft®) with the confidence level and confidence interval set at 
95% and 5% respectively. Recruitment of study participants was stopped at 95 (63% of target 
sample size) due to financial constraints. The study protocol of this was approved by the 
University of KwaZulu-Natal Biomedical Research Ethics Committee (reference: BFC098/16). 
 
Protocol 
This was a 10-day, multiple-arm randomized controlled trial designed to determine the effects 
of short-term CMIT and HIIT on insulin sensitivity (HOMA-IS), beta cell function (HOMA-β) 
and insulin resistance (HOMA-IR) in physically inactive, overweight/obese adults. Enrolled 
participants were screened for insulin resistance and categorized as insulin sensitive (IS; 
HOMA-IR > 1.1 - < 2) or insulin resistant (IR; HOMA-IR > 2) [34]. Using a pseudo-random 
number generator software (Research Randomizer version 4.0), participants in the IS and IR 
groups were assigned to a control group (CNT), continuous moderate intensity training (CMIT) 
or high intensity interval training (HIIT) sub-group. Participants in the CNT sub-group 
underwent baseline and follow-up evaluation without taking part in the intervention. The CMIT 
and HIIT sub-groups underwent baseline assessments, ten consecutive days of either CMIT or 
HIIT, and had follow-up evaluation after the exercise intervention period. Primary outcome 
measures included body mass index [BMI (kg/m2)], percentage body fat (%BF), HOMA-IS, 
HOMA- β, HOMA-IR and peak oxygen consumption (V ̇O2peak ). 
 
Baseline measurements included exercise pre-participation questionnaire, clinical examination, 
laboratory and physiological tests. A repeat of baseline measures was conducted at follow-up 
which was undertaken at least 24 hours after the last exercise bout, within a 48-hour period. 
Post-training blood draws were conducted at least 24 hours before V ̇O2peak test. 
 
The exercise pre-participation health screening questionnaire focused on the participant’s 
current level of physical activity as well as screening for signs or symptoms of cardio-metabolic 
disease; physical activity screening questionnaire (PASQ) and pre-exercise intervention 
questionnaire (PEIQ). The PASQ (themes; activity at work/school, travel to and from places, 
recreational activities and sedentary behaviour) was adapted from the World Health 
Organization (WHO) global physical activity questionnaire (GPAQ). The PEIQ (themes; history 
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of cardiovascular events, symptoms, other health issues and cardiovascular risk factors i.e. age, 
blood pressure and cholesterol) was adapted the American Council for Sport Medicine (ACSM) 
pre-participating questionnaire. 
 
Height (cm) was measured on a stadiometer without shoes. Waist circumference [WC (cm)] was 
measured at the approximate midpoint between the lower margin of the last palpable rib and 
the top of the iliac crest [27]. Hip circumference [HC (cm)] was measured around the widest part 
of the buttocks [27]. Height, WC and HC were all measured to the nearest centimeter. Waist and 
hip circumference were used to calculate waist-hip ratio (WHR). An electronic body 
composition monitor (Omron® BF511 Body Composition Scale) was used to measure body 
weight [BW (kg)], BMI, %BF, muscle mass percentage [MM (%)] and visceral fat (VF).  
 
Laboratory analyses were conducted at the Lancet Pathology Laboratory (Durban, South 
Africa). Following a 12-hour overnight fast by participants, venous blood samples were drawn 
from the ante cubital region of the arm, collected into plain tubes and NaF tubes for the analysis 
of insulin and glucose, respectively. The samples were stored at -80 °C until further biochemical 
analysis. Fasting serum insulin was measured by radioimmunoassay [28]. Fasting plasma 
glucose was measured using a glucose hexokinase method on a Roche automated analyzer [29, 
30]. The fasting insulin and glucose were used to calculate HOMA-%b, HOMA%S and HOMA-
IR (HOMA2 Calculator© The University of Oxford 2013) [31]. 
 
Physiological parameters, V ̇O2peak and power output (PO) were assessed by a 2-minute 
continuous incremental cycling test performed on an electronically braked ergometer (Lode 
Excalibur Sport, Groningen, The Netherlands) [32, 33]. After participants pedalled at 50 watts 
for 3 minutes (warm-up), the workload was increased by 25 watts every 2 minutes until 
volitional fatigue. Blood pressure (mmHg) (Omron® MIT Elite Plus Blood Pressure Monitor) 
and heart rate (bpm) (Polar S810TM HRM) were measured at rest (before the exercise test), every 
2 minutes during the V ̇O2peak test and post exercise testing until the values returned toward 
resting measures. Oxygen consumption (V ̇O2) was analyzed by an online breath by breath gas 
collection system (Cortex MetaMax 3b gas analyser). The highest V ̇O2 achieved during the last 
stage was recorded as the V ̇O2peak [34]. Studies have reported that acute exercise can influence 
insulin up to 72 hours post-exercise [35]. Thus, to minimize the effects of the V ̇O2peak test on 
insulin, cardiorespiratory fitness testing was conducted no less than 4 days before blood samples 
were collected [35]. Study participants were asked to refrain from exercise before blood samples 
were collected for insulin assay. 
 
The HIIT exercise protocol was designed based on findings from previous studies which 
indicated that during HIIT, a 2:1 work to rest ratio yields appropriate training stimulus and is 
perceived as less difficult by participants [36]. The CMIT group was matched for time. Exercise 
sessions were performed on an electronically braked cycle ergometer (Lode Excalibur Sport, 
Groningen, The Netherlands) for 10 consecutive days, with at least 24 hours in-between sessions. 
Study participants were afforded 3 minutes of warm-up and 3 minutes of cool-down on the 
ergometer at 50W and 60rpm. During active exercise, participants were required to maintain a 
workload that corresponded with a wattage that solicited 60-70% V ̇O2peak for the CMIT sub-
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group and 90-100% of V ̇O2peak for the HIIT. The workloads were determined from pre-
intervention V ̇O2peak assessments.  
 
The total time for exercise sessions started at 18 minutes and progressed to 24 minutes over the 
intervention period. In the current study, we were exploring one of the numerous work-to-rest 
ratios of HIIT. In studies on trained athletes, HIIT sessions are generally 15-30 minutes. 
However, little is known about the optimal tolerable combination of intensity and volume 
necessary for adaptations in clinical populations. The gradual progression in time and intensity 
was in accordance with American College of Sports Medicine Guidelines for Exercise testing and 
Prescription [37]. Over the 10 days of exercise intervention, the HIIT group spent 33.3% less time 
in active exercise than the CMIT group, 96 minutes versus 144 minutes of CMIT. Exercise 
sessions were performed under standard laboratory conditions. The primary investigator 
documented attendance and ensured that sessions were performed as prescribed. Post-training 
assessments (repeat of baseline measures) were conducted at least 24 hours after the last exercise 
bout, within a 48-hour period. A summary of procedures conducted at baseline, during the 
intervention and post intervention is shown in Table 1, below. 
 






questionnaire Conducted only at baseline 
Clinical examination 
Conducted between 07:00-09:00 AM Venipuncture 







Days 1-4 5-8 9-10 
Warm-up at 50W and 60rpm for 3 minutes 
CMIT sessions 12 min cycling with no rest 1 set 
15 min cycling with no rest 
1 set 




60 sec cycling/30 sec rest 
8 sets 
60 sec cycling/30 sec rest 
10 sets 
60 sec cycling/30 sec of rest 
12 sets 











Conducted between 07:00-09:00 AM, 24 hrs after the last exercise bout 
Venipuncture 
Aerobic fitness test Conducted 24 hrs after venipuncture within 48 hrs of the last exercise bout 
Note: CMIT; continuous moderate intensity training, HIIT; high intensity interval training, RPM; revolutions per 
minute, Hrs; hours 
 
Statistical Analysis 
Data was analyzed using SPSS version 24 (IBM, USA). Values are expressed as means and 
standard deviations (SD). Descriptive statistics were conducted to examine the general 
characteristics of study participants such as age, BMI, HOMA-IR and V ̇O2peak. The independent 
t-test was applied to compare the means at baseline between the sub-groups (CNT, CMIT and 
HIIT) to ensure no significant differences at the baseline. The comparison was also made 
between insulin sensitive and insulin resistant participants in the sub-groups. A repeated 
measure analysis of variable (ANOVA) was used to examine the interaction effect (sub-group × 
time) for all variables. Where appropriate, pairwise multiple comparison were performed using 
the Bonferroni post-hoc test. The significance level was set at p < 0.05. Percentage changes from 
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baseline to follow-up were calculated for all outcome variables. To determine the magnitude of 
the changes from baseline to follow-up, Cohen’s (d) effect sizes 95% confidence intervals (CI) 
were calculated. Magnitudes of the standardized effects were interpreted using thresholds of d 
≤ 0.2 (small), d ≥ 0.5 (moderate) and d ≥ 0.8 (large) [38]. An effect size was only accepted if the 
confidence interval did not cross both the positive and negative 0.2 ES thresholds otherwise 




A total of 95 participants were enrolled into the study. Of these, 38 (40%) were male and 57 (60%) 
were female. The mean age and BMI were 23 ± 3.9 years and 32.1 ± 5.0 kg/m2, respectively. 
Figure 1 outlines the consort diagram. Of the total study group (n = 95), 60 participants (63%) 
were categorized as insulin sensitive (IS) and 35 (37%) as insulin resistant (IR). When the IS and 
IR groups were randomised into sub-groups, the CNT and HIIT sub-groups each included 31 
participants: IS (n = 20) and IR (n = 11); the CMIT sub-group had 33 participants: IS (n = 20) and 
IR (n = 13).  
 
Sixty participants were included in the pre-versus post-intervention analysis; of these, 31 were 
from the insulin sensitive group [CNT (n = 9); HIIT (n = 11); CMIT (n = 11)] and 29 from the 
insulin resistant group [CNT (n = 5); HIIT (n = 11); CMIT (n = 13)].  
 
Thirty-five participants were lost to follow-up, of whom 29 were from the insulin sensitive 
group [CNT (n = 10); HIIT (n = 8); CMIT (n = 11)], and 6 were from the insulin resistant CNT 
group (n = 6). Reasons for discontinuing the study were, relocation (to study at other institutions 
or for employment) and busy schedule. There was no statistically significant difference in 
baseline characteristics between participants who completed the study and those who did not.  
 
Table 2 shows baseline characteristics of the sub-sample that was followed-up (n = 60). When 
compared with IS participants, those with IR had significantly higher HOMA-IR in all sub-
groups; CNT (p = 0.00), CMIT (p = 0.01) and HIIT (p = 0.02). IR participants had significantly 
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Figure 1. Consort diagram. IS-insulin sensitive; IR-insulin resistant; CNT-control; CMIT-continuous moderate 
intensity training; HIIT-high intensity interval training; BMI-body mass index. 
 
Analyzed (n = 31) 
CNT (n = 9) 
CMIT (n = 10) 
HIIT (n = 12) 
 
 
 IS (n = 60) IR (n = 35) 
10-day follow-up 
CNT (n = 20) 
CMIT (n = 20) 
HIIT (n = 20) 
 
CNT (n = 11) 
CMIT (n = 13) 
HIIT (n = 11) 
 
Analysis 
Lost to follow-up (n = 6) with reasons 
§ CNT (n = 6); Reason: Busy schedule (n = 1), 
Relocation (n = 5) 
§ CMIT (n = 0) 
§ HIIT (n = 0) 
 
Participants assessed for eligibility 
(n = 142) 
Excluded (n = 47) 
§ BMI < 25 kg/m2 (n = 13) 
§ > 30 min of exercise/week (n = 20) 
§ Medication (n = 1) 
§ Smokers (n = 10) 
§ Out of age range (n = 2) 
§ Medication (n = 1) 
 
Lost to follow-up (n = 29) with reasons 
§ CNT (n = 11); Reason: Busy schedule (n = 6), 
Relocation (n = 5) 
§ CMIT (n = 10); Reason: Relocation (n = 10) 
§ HIIT (n = 8); Reason: Relocation (n = 8) 
 
 
Eligible (n = 95) 
Analyzed (n = 29) 
CNT (n = 5) 
CMIT (n = 13) 
HIIT (n = 11) 
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Table 2. Baseline characteristics of the sub-sample that was followed-up (n:60) by training intensity. 
Characteristics 
CNT (n = 14) CMIT (n = 23) HIIT (n = 23) 
IS mean 
(SD) 
IR mean (SD) IS mean 
(SD) 




IR mean (SD) 




































































































Note: Data are expressed as mean (SD). CNT: control; CMIT: continuous moderate intensity training; HIIT: high 
intensity interval training;  IS: insulin sensitive; IR: insulin resistant; BMI: body mass index; BF: body fat; FBG: 
fasting blood glucose; HOMA-%ß: homeostasis model of assessment for beta-cell function; HOMA: %S: 
Homeostasis Model of Assessment for insulin sensitivity; HOMA-IR: homeostatic model of assessment for insulin 
resistance;  V̇O2peak: peak oxygen consumption. *p < 0.05: IS vs IR. Fasting glucose reference range: 3.3-6.0 mmol/L. 
 
Table 3 shows percentage changes in the insulin resistance (IR) group at follow-up (n = 24). High 
intensity interval training increased HOMA-%S by 33.3% vs. 9.33% in the continuous moderate 
intensity training (CMIT) sub-group. Insulin resistance (HOMA-IR) was reduced by 32.4% in 
the HIIT sub-group vs 6.45% in the CMIT sub-group. 
 
Cohen’s effect sizes (ES) showed that the effects of CMIT on HOMA-%S and HOMA-IR were 
unclear in the insulin resistant group while HIIT produced a large (ES: d = 0.9; 95% CI: 0.04.7, 
1.8) increase in HOMA-%S and large (ES: d = -0.9; 95% CI: -1.7, -0.1) decrease in HOMA-IR. 
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Table 3. Changes in characteristics of the insulin resistant (IR) group from baseline to follow-up  













































































































Note: Data are expressed as mean (SD). CNT: control; CMIT: continuous moderate intensity training; HIIT: high 
intensity interval training; IS: insulin sensitive; IR: insulin resistant; BMI: body mass index; BF: body fat; FBG: 
fasting blood glucose; HOMA-%ß: homeostasis model of assessment for beta-cell function; HOMA: %S: 
Homeostasis Model of Assessment for insulin sensitivity; HOMA-IR: homeostatic model of assessment for insulin 




This study on physically inactive overweight and obese adults has shown that CMIT or HIIT for 
10 consecutive days does not result in statistically significant improvements in beta cell function, 
insulin sensitivity and insulin resistance. Cohen’s (d) effects sizes showed that in insulin 
resistant individuals, HIIT leads to a large (33.3%) increase and a large (32.4%) decrease in 
insulin sensitivity and insulin resistance, respectively. Thus, although not statistically 
significant, the effects of HIIT on insulin sensitivity and insulin resistance may be of clinical 
relevance.  
 
The absence of statistically significant changes (based on p-value statistics) in cardiometabolic 
parameters may be due to small sample size and may not directly indicate that an effect does 
not exist [39, 40]. Cohen’s effect sizes indicated that HIIT produced a large (d = 0.9) increase in 
HOMA%S and a large (d = -0.9) decrease in HOMA-IR while those of CMIT were unclear. 
Previous studies have indeed reported that  when compared with CMIT, HIIT results in similar 
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improvements in insulin sensitivity and insulin resistance even with the significantly reduced 
time spent exercising for the HIIT groups [41-43]. In those studies, however, there was 
concomitant improvement in cardiovascular fitness and decreases in body fat following HIIT. 
Improved cardiovascular fitness and decreased body fat have been reported to independently 
improve insulin sensitivity. Consequently, this presents a challenge in drawing conclusions on 
whether the improvements were from the exercise per se. In the present study, the positive effects 
of HIIT on insulin sensitivity and insulin resistance occurred in the absence of changes in body 
composition and cardiorespiratory fitness, suggesting that the observed improvements may be 
related to HIIT training. Possible mechanism for HIIT-induced metabolic adaptations include 
enhanced insulin signaling in skeletal muscle via increased insulin-stimulated phosphorylation 
of AS160 which regulates GLUT4 translocation [44].  Our findings however, are to be interpreted 
cautiously as other studies have found no clear advantage in the improvement of insulin 
sensitivity in short-term studies [45]. 
 
The strengths of this study include the randomized controlled design, categorization of 
participants into insulin sensitive and insulin resistant groups and use of Cohens (d) effect sizes 
to quantify the effects of the exercise intervention. Our study findings, however, need to be 
interpreted with caution. Limitations included high attrition rate, small sample and 
uncontrolled diet. Relocation to areas outside the study site and frequent visits to the laboratory 
may have contributed to the high attrition rate.  The small sample size (63% of the estimated 
sample) which decreased the statistical power of the study. Participants were asked to maintain 
their regular diet, some individuals however, may have been encouraged to make healthier 
dietary choices upon enrollment into the study, this may have influenced the results.  
 
Future large-scale studies with controlled diet and a broader representation of the South African 
population are necessary to enable a much wider interpretation and application of the findings. 
Furthermore, the current study explored one of the numerous possible combinations of work to 
rest ratio during HIIT. The ideal HIIT exercise prescription for individuals with insulin 
resistance/diabetes remains to be elucidated. Studies to establish the ideal combination of work 
to rest ratio, frequency and duration during HIIT training are needed. 
 
In conclusion, the present study revealed that CMIT or HIIT for 10 consecutive days does not 
result in statistically significant improvements in beta cell function, insulin sensitivity and 
insulin resistance. However, future large-scale studies to clarify and confirm the effects of CMIT 
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